DIHYDROERGOTAMINE MESYLATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for dihydroergotamine mesylate and what is the scope of freedom to operate?
Dihydroergotamine mesylate
is the generic ingredient in five branded drugs marketed by Bausch, Cipla, Gland Pharma Ltd, Hikma, Hikma Pharms, Padagis Us, Provepharm Sas, Sagent Pharms Inc, Amneal, Rubicon, Impel Pharms, and Novartis, and is included in fifteen NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.Dihydroergotamine mesylate has sixty-four patent family members in sixteen countries.
There are six drug master file entries for dihydroergotamine mesylate. Ten suppliers are listed for this compound.
Summary for DIHYDROERGOTAMINE MESYLATE
International Patents: | 64 |
US Patents: | 6 |
Tradenames: | 5 |
Applicants: | 12 |
NDAs: | 15 |
Drug Master File Entries: | 6 |
Finished Product Suppliers / Packagers: | 10 |
Raw Ingredient (Bulk) Api Vendors: | 48 |
Clinical Trials: | 16 |
Patent Applications: | 2,004 |
Drug Prices: | Drug price trends for DIHYDROERGOTAMINE MESYLATE |
What excipients (inactive ingredients) are in DIHYDROERGOTAMINE MESYLATE? | DIHYDROERGOTAMINE MESYLATE excipients list |
DailyMed Link: | DIHYDROERGOTAMINE MESYLATE at DailyMed |
Recent Clinical Trials for DIHYDROERGOTAMINE MESYLATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ache Laboratorios Farmaceuticos S.A. | Phase 3 |
Xijing Hospital | Phase 2/Phase 3 |
Satsuma Pharmaceuticals, Inc. | Phase 3 |
Pharmacology for DIHYDROERGOTAMINE MESYLATE
Drug Class | Ergotamine Derivative |
Medical Subject Heading (MeSH) Categories for DIHYDROERGOTAMINE MESYLATE
Anatomical Therapeutic Chemical (ATC) Classes for DIHYDROERGOTAMINE MESYLATE
US Patents and Regulatory Information for DIHYDROERGOTAMINE MESYLATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Impel Pharms | TRUDHESA | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 213436-001 | Sep 2, 2021 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Impel Pharms | TRUDHESA | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 213436-001 | Sep 2, 2021 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Hikma | DIHYDROERGOTAMINE MESYLATE | dihydroergotamine mesylate | INJECTABLE;INJECTION | 040453-001 | Jun 9, 2003 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Novartis | EMBOLEX | dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride | INJECTABLE;INJECTION | 018885-001 | Nov 30, 1984 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DIHYDROERGOTAMINE MESYLATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch | MIGRANAL | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 020148-001 | Dec 8, 1997 | ⤷ Subscribe | ⤷ Subscribe |
Bausch | MIGRANAL | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 020148-001 | Dec 8, 1997 | ⤷ Subscribe | ⤷ Subscribe |
Bausch | MIGRANAL | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 020148-001 | Dec 8, 1997 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DIHYDROERGOTAMINE MESYLATE
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 3111516 | DISPOSITIF D'ADMINISTRATION DE MEDICAMENT PAR VOIE NASALE (NASAL DRUG DELIVERY DEVICE) | ⤷ Subscribe |
Japan | 2020185475 | 直列形経鼻送達デバイス (IN-LINE NASAL DELIVERY DEVICE) | ⤷ Subscribe |
European Patent Office | 3735244 | ADMINISTRATION INTRANASALE DE DIHYDROERGOTAMINE PAR UN DISPOSITIF OLFACTIF DE PRÉCISION (INTRANASAL DELIVERY OF DIHYDROERGOTAMINE BY PRECISION OLFACTORY DEVICE) | ⤷ Subscribe |
Australia | 2016256665 | Nasal drug delivery device | ⤷ Subscribe |
>Country | >Patent Number | >Title | >Estimated Expiration |
DIHYDROERGOTAMINE MESYLATE Market Analysis and Financial Projection Experimental
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.